| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/20/2005 | US20050014150 Screening eukaryotic messenger RNA sequences and identifying internal ribosome entry site (IRES) elements for use in cap-independent expression of foreign genes in eukaryotic cells; enhancing in vitro translation heterologous |
| 01/20/2005 | US20050014149 Assay for inhibitors of translocases |
| 01/20/2005 | US20050014147 Method and apparatus for three label microarrays |
| 01/20/2005 | US20050014145 Using gross anatomical features and cationic dye staining of head, neck and saliva tissues as indicator tools in the detection cell proliferative disorders |
| 01/20/2005 | US20050014144 Prediciting strobilurin resistance in fungi via presence of polymorphic sequences in cytochrome b gene; allele specific oligonucleotide hybridization and nucleotide sequence amplification |
| 01/20/2005 | US20050014143 Using chloroplast and/or mitochondrial DNA sequences as diagnostic and replication tools for classifying and determining evoultionary relationships between species |
| 01/20/2005 | US20050014142 Hybridization normalization methods |
| 01/20/2005 | US20050014140 Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes |
| 01/20/2005 | US20050014137 Using high throughput screening to identify viricidal agents which suppress regulatory activities of viral infectivity factors (VIF) and prevent viral infection and diseases |
| 01/20/2005 | US20050014133 Using DNA viral sequences to diagnose, prognose and classify cell proliferative disorders of female urogenital system; proteomics |
| 01/20/2005 | US20050014132 Using the proteomic profiles of cells as tool in detecion of immunological, neurological, metabolic, oncological, viral, or a cardiovascular disorder; drug screening; high through put assay |
| 01/20/2005 | US20050014129 Device and methods for detecting the response of a plurality of cells to at least one analyte of interest |
| 01/20/2005 | US20050014128 Exposing the blood sample to an enzyme-detergent combination such as plasminogen and streptokinase, and analyzing the exposed blood sample for the presence of particles |
| 01/20/2005 | US20050014027 Crosslinked polymer doped with iron oxide; diagnosis of nucleic acids |
| 01/20/2005 | US20050013827 Novel molecules of the herpesvirus-entry-mediator-related protein family and uses thereof |
| 01/20/2005 | US20050013818 Compositions and methods for the suppression of mammary epithelial cell proliferation |
| 01/20/2005 | US20050013817 Human SMAPK3-related gene variants associated with cancers |
| 01/20/2005 | US20050013803 Diagnosing and treating cancer cells using mutant viruses |
| 01/20/2005 | US20050013796 Detection and treatment of breast disease |
| 01/20/2005 | US20050013776 Obtaining control data from long term study; subjecting sample groups to same diet program for varied time periods; comparing results to control |
| 01/20/2005 | US20050013730 Items and their treatment |
| 01/20/2005 | DE10330234A1 Verfahren zum Identifizieren von fungizid wirksamen Verbindungen basierend auf Mevalonat Kinasen aus Pilzen A method for identifying fungicidally active compounds based on mevalonate kinases from fungi |
| 01/20/2005 | DE10330233A1 Verfahren zum Identifizieren von funigzid wirksamen Verbindungen basierend auf Guanylat Kinasen A method for identifying compounds effective funigzid based on guanylate kinases |
| 01/20/2005 | DE10329240A1 Verfahren zur Analyse des Cytosin-Methylierungsstatus von Cancer-Testis-Antigenen für eine individualisierte Immuntherapie Method for the analysis of cytosine methylation status of Cancer-testis antigens for an individualized immunotherapy |
| 01/20/2005 | DE10329091A1 Testing blood or pharmaceutical products for contamination by pathogens, comprises incubating with monocytes and testing for induction of cytokine-encoding mRNA |
| 01/20/2005 | DE10328775A1 In vivo-Testsystem zum Nachweis von HIV-Proteaseaktivität In vivo test system for the detection of HIV protease activity |
| 01/20/2005 | DE10327683A1 Verfahren und Vorrichtung zum quantitativen elektrischen Nachweis von Analyten Method and apparatus for the quantitative detection of analytes electrical |
| 01/20/2005 | DE10325300A1 Thermocycler Thermocycler |
| 01/20/2005 | CA2559791A1 Secreted proteins as markers for cell differentiation |
| 01/20/2005 | CA2532196A1 Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof |
| 01/20/2005 | CA2532150A1 Method of evaluating compound efficacious in treating obesity |
| 01/20/2005 | CA2531630A1 Glutamine:fructose-6-phosphate amidotransferase (gfat) comprising an internal purification marker and use thereof for the screening of compounds |
| 01/20/2005 | CA2531494A1 Method of screening for improved specific activity of enzymes |
| 01/20/2005 | CA2531420A1 Diagnosis and treatment methods related to aging (8a) |
| 01/20/2005 | CA2531345A1 Polydiacetylene-containing solid colorimetric and/or fluorescent detector, method for its preparation and uses thereof |
| 01/20/2005 | CA2531339A1 Fluorine nmr spectroscopy for biochemical screening |
| 01/20/2005 | CA2531091A1 Genes regulated in ovarian cancer as prognostic and therapeutic targets |
| 01/20/2005 | CA2530785A1 2'-terminator nucleotide-related methods and systems |
| 01/20/2005 | CA2530029A1 Mutant adeno-associated virus virions and methods of use thereof |
| 01/20/2005 | CA2529509A1 Methods for the stereoselective synthesis and enantiomeric enrichment of .beta.-amino acids |
| 01/20/2005 | CA2529278A1 Improved method for the determination of the presence of an antibiotic in a fluid |
| 01/20/2005 | CA2528901A1 Improved test system for the determination of the presence of an antibiotic in a fluid |
| 01/20/2005 | CA2528669A1 Compositions and methods for treating and diagnosing cancer |
| 01/20/2005 | CA2528120A1 Methods for treating lentivirus infections |
| 01/20/2005 | CA2527537A1 Modulation of c-reactive protein expression |
| 01/19/2005 | EP1498732A2 A one-step assay for high-density lipoprotein cholesterol |
| 01/19/2005 | EP1498497A2 Method of nucleic acid analysis by mass spectrometry |
| 01/19/2005 | EP1498496A2 DNA probe specific for Staphylococcus epidermidis |
| 01/19/2005 | EP1498495A2 DNA probe specific for Staphylococcus epidermidis |
| 01/19/2005 | EP1498494A2 Method of nucleic acid sequencing |
| 01/19/2005 | EP1498493A1 Method of examining allergic disease |
| 01/19/2005 | EP1498492A1 Apparatus for the preparation of samples |
| 01/19/2005 | EP1498124A2 The use of inhibitors of the renin-angiotensin system |
| 01/19/2005 | EP1498025A2 Automated system and method for harvesting and multi-stage screening of plant embryos |
| 01/19/2005 | EP1497797A2 2150, a human protein kinase family member and uses therefor |
| 01/19/2005 | EP1497662A1 Uses of the carbamoyl phosphate synthesis 1 (cps 1) and the fragments thereof for the diagnosis of inflammatory diseases and sepsis |
| 01/19/2005 | EP1497661A1 Diagnostic and therapeutic use of ensadin-0477 gene and protein for neurodegenerative diseases |
| 01/19/2005 | EP1497659A2 An ephrin-b receptor protein involved in carcinoma |
| 01/19/2005 | EP1497658A2 Protein involved in cancer |
| 01/19/2005 | EP1497657A2 Method for characterizing primary tumors |
| 01/19/2005 | EP1497656A2 Diagnosis of carcinoma using raig1 polypeptides |
| 01/19/2005 | EP1497655A1 Enhanced gene expression system |
| 01/19/2005 | EP1497648A2 Methods for identifying allosteric sites |
| 01/19/2005 | EP1497647A1 Test for measurement of therapeutic drug levels |
| 01/19/2005 | EP1497646A2 Peptide biomarker and method of identification |
| 01/19/2005 | EP1497642A2 Gene amplification in cancer |
| 01/19/2005 | EP1497570A2 Collision energy-absorbing device |
| 01/19/2005 | EP1497470A2 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 01/19/2005 | EP1497469A2 Assay for evaluation of activity of compounds against hcv using a novel detection system in the hcv replicon |
| 01/19/2005 | EP1497468A1 Cells for detection of influenza and parainfluenza viruses |
| 01/19/2005 | EP1497467A2 Oligonucleotides from sequences coding for the surface component of ptlv envelope proteins and uses thereof |
| 01/19/2005 | EP1497466A2 Binary or polynary targeting and uses thereof |
| 01/19/2005 | EP1497465A2 Constant length signatures for parallel sequencing of polynucleotides |
| 01/19/2005 | EP1497464A1 Compositions and methods related to two-arm nucleic acid probes |
| 01/19/2005 | EP1497463A1 Methods to predict patient responsiveness to tyrosine kinase inhibitors |
| 01/19/2005 | EP1497462A2 Genomic screen for epigenetically silenced genes associated with cancer |
| 01/19/2005 | EP1497461A2 Methods of assaying for cell cycle modulators |
| 01/19/2005 | EP1497460A1 Diagnostic and therapeutic use of ensadin-0138 gene and protein for neurodegenerative diseases |
| 01/19/2005 | EP1497459A2 A device and methods for concentrating prion protein isoforms |
| 01/19/2005 | EP1497458A2 Hydrophobic zone device |
| 01/19/2005 | EP1497457A1 Method and kit for detecting membrane protein-protein interactions |
| 01/19/2005 | EP1497456A1 Method for the preparation of reagents for amplification and/or detection of nucleic acids that exhibit no significant contamination by nucleic acids |
| 01/19/2005 | EP1497455A2 Detection of nucleic acid sequences by cleavage and separation of tag-containing structures |
| 01/19/2005 | EP1497454A2 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
| 01/19/2005 | EP1497453A1 Methods for measuring protein kinase and phosphatase activity |
| 01/19/2005 | EP1497452A2 Methods for measuring enzyme activity |
| 01/19/2005 | EP1497451A1 Method and device for detecting toxic material in water using microbial fuel cell |
| 01/19/2005 | EP1497450A2 Methods for identifying compounds that modulate enzymatic activity |
| 01/19/2005 | EP1497449A1 Disposable sensor with enhanced sample port inlet |
| 01/19/2005 | EP1497448A1 Methods and compound mixtures for determining protein activity using nmr spectroscopy |
| 01/19/2005 | EP1497447A2 Ecist microarrays for dual screening of dna hypermethylation and gene silencing, and for use in an integrated system for assessing gene expression, dna methylation and histone acetylation |
| 01/19/2005 | EP1497446A1 Disposable sub-microliter volume sensor with enhanced sample inlet |
| 01/19/2005 | EP1497442A2 Biologic modulations with nanoparticles |
| 01/19/2005 | EP1497434A2 Matrix analysis of gene expression in cells (magec) |
| 01/19/2005 | EP1497427A2 Helicokinin-receptor from insects |
| 01/19/2005 | EP1497426A2 Co-stimulatory molecules |
| 01/19/2005 | EP1497425A2 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle |
| 01/19/2005 | EP1497422A2 La1 - the genome of a lactobacillus strain |
| 01/19/2005 | EP1497419A1 Nucleic acid molecule encoding a variant ddah 1 protein and uses thereof |
| 01/19/2005 | EP1497418A2 Phospholipases, nucleic acids encoding them and methods for making and using them |